Fortunately, in this study, we found that FAD repressed the STAT3 expression in HCC cells, and the use of SC144 further enhanced the promotion of FAD on DDP chemosensitivity of HCC. The gene discussed is STAT3; the disease is hepatocellular carcinoma.